Sanofi SA

Common Name

Sanofi

Country

France

Sector

Healthcare

Industry

Drug Manufacturers - General

Employees

82,878

Ticker

SAN

Exchange

EURONEXT

Website

www.sanofi.com

Description

Sanofi is a leading global pharmaceutical company, renowned for its extensive research, development, and distribution of therapeutic solutions. Primarily focusing on patient healthcare, Sanofi operate... Show more

Income Statement Balance Sheet Group Entities

Sanofi's Financial Statements Preview

Below are the financial statements of Sanofi, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

Interested in getting early access to our real-time standardized financial datafeed?

Learn More

All figures in billions of EUR	2024 as of 2024-12-31	2023 as of 2023-12-31	2022 as of 2022-12-31
Assets	—	—	—
Property, plant and equipment	10.09^a	10.16^a	9.87^a
Right-of-use assets	1.51^a	1.65^a	1.82^a
Goodwill	43.38^a	49.4^a	49.89^a
Other intangible assets	22.63^a	24.32^a	21.64^a
Investments accounted for using the equity method	0.32^a	0.42^a	0.68^a
Other non-current assets	3.75^a	3.22^a	3.1^a
Non-current income tax assets	0.56^a	0.19^a	0.24^a
Deferred tax assets	7.97^a	6.43^a	5.38^a
Non-current assets	90.21^a	95.79^a	92.61^a
Inventories	9.43^a	9.67^a	8.96^a
Accounts receivable	7.68^a	8.43^a	8.42^a
Other current assets	3.83^a	3.46^a	3.53^a
Current income tax assets	0.72^a	0.39^a	0.37^a
Cash and cash equivalents	7.44^a	8.71^a	12.74^a
Assets held for sale	13.49^a	0.02^a	0.09^a
Current assets	42.59^a	30.67^a	34.11^a
Total assets	132.8^a	126.46^a	126.72^a
Equity and liabilities	—	—	—
Equity attributable to equity holders of Sanofi	77.51^a	74.04^a	74.78^a
Equity attributable to non-controlling interests	0.35^a	0.31^a	0.37^a
Total equity	77.86^a	74.35^a	75.15^a
Long-term debt	11.79^a	14.35^a	14.86^a
Non-current lease liabilities	1.65^a	1.76^a	1.9^a
Non-current liabilities related to business combinations and to non-controlling interests	0.57^a	0.5^a	0.67^a
Non-current provisions and other non-current liabilities	8.1^a	7.6^a	6.34^a
Non-current income tax liabilities	1.51^a	1.84^a	1.98^a
Deferred tax liabilities	2.17^a	1.86^a	1.84^a
Non-current liabilities	25.78^a	27.9^a	27.6^a
Accounts payable	7.55^a	7.33^a	6.81^a
Current liabilities related to business combinations and to non-controlling interests	0.07^a	0.21^a	0.11^a
Current provisions and other current liabilities	14.24^a	13.74^a	12.02^a
Current income tax liabilities	0.7^a	0.6^a	0.57^a
Current lease liabilities	0.26^a	0.28^a	0.28^a
Short-term debt and current portion of long-term debt	4.21^a	2.05^a	4.17^a
Liabilities related to assets held for sale	2.13^a	0.01^a	0.01^a
Current liabilities	29.16^a	24.21^a	23.97^a
Total equity and liabilities	132.8^a	126.46^a	126.72^a

Download Data

Verified Sources Behind Sanofi’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Sanofi’s data sources below and access millions more through our Disclosure Search.

a. Sanofi's Annual Report 2024

Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

Tracenable is building real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?

Explore Peer Companies

Welcome Back to Tracenable

Sign in to your account

Sanofi SA

Sanofi's Financial Statements Preview

Verified Sources Behind Sanofi’s Financial Fundamentals Data

Access Standardized Financial Statements within Minutes of Disclosure

Explore Peer Companies

Virbac SA

Merck & Co Inc

Roche Holding AG

AstraZeneca PLC

Gilead Sciences Inc

Novo Nordisk A/S